AI assistant
Sending…
AbbVie Inc. — Director's Dealing 2017
Jun 15, 2017
29755_dirs_2017-06-15_c96f72ee-b4c4-44b2-b2e5-faf461f4c94e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2017-06-14
Reporting Person: Schumacher Laura J (Executive Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-06-14 | Common stock, $0.01 par value | M | 79800 | $29.2265 | Acquired | 187625 | Direct |
| 2017-06-14 | Common stock, $0.01 par value | S | 79800 | $70 | Disposed | 107825 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-06-14 | Option (right to buy) | $29.2265 | M | 79800 | Disposed | 2022-02-16 | Common stock (79800) | Direct |
More from AbbVie Inc.
Regulatory Filings
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 12
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 29
Capital/Financing Update
2026
Apr 3
Major Shareholding Notification
2026
Mar 26
Proxy Solicitation & Information Statement
2026
Mar 23
Proxy Solicitation & Information Statement
2026
Mar 23
Capital/Financing Update
2026
Mar 4
Director's Dealing
2026
Mar 4